Log in to save to my catalogue

Hypertrophic lichenoid dermatitis during pembrolizumab treatment

Hypertrophic lichenoid dermatitis during pembrolizumab treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff05807055ca407aac88b48d6467122a

Hypertrophic lichenoid dermatitis during pembrolizumab treatment

About this item

Full title

Hypertrophic lichenoid dermatitis during pembrolizumab treatment

Publisher

Tokyo: Frontiers Media SA

Journal title

Journal of cutaneous immunology and allergy, 2021-08, Vol.4 (4), p.96-97

Language

English

Formats

Publication information

Publisher

Tokyo: Frontiers Media SA

More information

Scope and Contents

Contents

Immunohistochemical findings of biopsy (D-F) and normal skin (control) (G); the expression of dermal CD8+ T cells (D) and keratinocytic PD-L1 (E, F) was positive, although the expression of PD-L1 in keratinocyte was not clearly observed in normal skin (G) (brown) (original magnification, D, E, and G, ×40/F, ×200) An irAE is an autoimmune-like or in...

Alternative Titles

Full title

Hypertrophic lichenoid dermatitis during pembrolizumab treatment

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_ff05807055ca407aac88b48d6467122a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ff05807055ca407aac88b48d6467122a

Other Identifiers

ISSN

2574-4593

E-ISSN

2574-4593

DOI

10.1002/cia2.12179

How to access this item